{
    "paper_id": "e3746c8f9752226fe5ee84829058c36f97ef9ed6",
    "metadata": {
        "title": "Journal Pre-proofs Letter to the Editor Response to COVID -19 and Diabetes: Can DPP4 Inhibition Play a Role? - GLP-1 Might Play One Too",
        "authors": [
            {
                "first": "Nathaniel",
                "middle": [],
                "last": "Morin",
                "suffix": "",
                "affiliation": {},
                "email": "nathaniel.morin@ahs.ca"
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Hello, I recently came across your commentary on the function of dipeptidyl peptidase 4 (DPP-4), its possible role in coronavirus infection, and your hypothesis that DPP-4 inhibition may play a role in severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) treatment 1 . As my role is in surgery, acute systemic inflammation in people with type two diabetes is always on my mind to improve perioperative glycaemia and outcomes. I wanted to add to your discussion based on my experience in this field.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Endogenous cortisol, catecholamines and Interleukin-6 (IL-6) are main drivers in the post-operative stress response, causing insulin resistance and resulting in hyperglycemia in people with diabetes 2 . This effect is so dramatic after cardiac surgery that up to 80% of people develop hyperglycemia regardless of diabetes status 3 . Post-operative IL-6 increase has shown to cause glucacon like peptide 1 (GLP-1) release 4 , and GLP-1 analogue administration has shown efficacy in reducing post-operative hyperglycemia brought on by cardiac surgery 5 . Pre-operative administration of GLP-1 analogues have also shown efficacy in reducing post-operative hyperglycemia 6 , including superiority compared to preoperative long acting insulin 7 . Unfortunately, DPP-4 inhibitors have yet to show the same degree of efficacy in this regard 8,9 . As many people are likely taking GLP-1 analogues while mildly ill with SARS-COV-2, it may also be worthwhile studying the effects of GLP-1 analogues in preventing or reducing the sustained hyperglycemia resulting from systemic inflammation related to SARS-COV-2 infection. Based on their efficacy in preventing and treating hyperglycemia related to systemic inflammation after cardiac and non-cardiac surgery, GLP-1 analogues may play an important future role as well.",
            "cite_spans": [
                {
                    "start": 667,
                    "end": 668,
                    "text": "6",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 834,
                    "end": 839,
                    "text": "8,9 .",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Thank you for your time, and stay well soon.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "COVID-19 and diabetes: Can DPP4 inhibition play a role?",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Iacobellis",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Postoperative inflammation and insulin resistance in relation to body composition, adiposity and carbohydrate treatment: a randomized controlled study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Terwari",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Awad",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Duska",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Williams",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bennett",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "A"
                    ],
                    "last": "Macdonald",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lobo",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Clinical Nutrition",
            "volume": "38",
            "issn": "",
            "pages": "204--212",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Perioperative Hyperglycemia Management an update",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "W"
                    ],
                    "last": "Duggan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Carlson",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Umpierrez",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Anesthesiology",
            "volume": "126",
            "issn": "",
            "pages": "547--60",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Interleukin-6 predicts inflammation induced increase of Glucagon like peptide 1 in humans in response to cardiac surgery with association to parameters of glucose metabolism",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Labherz",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Kahles",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Piotrowski",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Vogeser",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Foldenauer",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Nassau",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Kilger",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Cardiovasc Diabetol",
            "volume": "15",
            "issn": "",
            "pages": "21--22",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "LIraglutide for perioperative management of hyperglycemia in cardiac surgery patients: a multicenter randomized superiority trial. Diabetes, Obesity and Metabolism",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "H"
                    ],
                    "last": "Hulst",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Visscher",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B"
                    ],
                    "last": "Godfried",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Thiel",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "M"
                    ],
                    "last": "Gerritse",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "V"
                    ],
                    "last": "Scohy",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Bouwman",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "22",
            "issn": "",
            "pages": "557--565",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "GLP1 Receptor agonist liraglutide is an effective therapeutic option for perioperative glycemic control in type two diabetes within enhanced recovery after surgery (ERAS) protocols",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kaneko",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ueda",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tahara",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Eur Surg Res",
            "volume": "59",
            "issn": "",
            "pages": "349--360",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Liraglutide is a perioperative therapeutic option for patients with type two diabetes that undergo elective surgery",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Katagiri",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Kigawa",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yahara",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ueda",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hamano",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kaneko",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Int J Diabetes Clin Diagn",
            "volume": "3",
            "issn": "",
            "pages": "1--5",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Glycaemic efficacy and safety of linagliptin compared to a basal bolus insulin regimen in patients with type two diabetes undergoing non-cardiac surgery: A multicenter randomized clinical trial",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Vellanki",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Rasouli",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Baldwin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Alexanian",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Anzola",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Urrutia",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Cardona",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Diabetes, Obesity and Metabolism",
            "volume": "21",
            "issn": "4",
            "pages": "837--843",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fayfman",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Davis",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Duggan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Urrutia",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chachkhiani",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Shindler",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Pasquel",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Journal of Diabetes and its complications",
            "volume": "32",
            "issn": "12",
            "pages": "1091--1096",
            "other_ids": {}
        }
    },
    "ref_entries": {},
    "back_matter": []
}